Scientech Research »

Acasti Pharma shares owned by Scientech Research

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by Scientech Research

Quarter filed Position value Share count Share price at filing
2026-06-30 $23k 10k 2.27

More positions owned by Scientech Research

MaxLinear (MXL)
Fuelcell Energy Com New (FCEL)
Astera Labs (ALAB)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Applied Materials (AMAT)
Palo Alto Networks (PANW)
Tesla Motors (TSLA)
Crowdstrike Hldgs Cl A (CRWD)
Tempus Ai Cl A (TEM)
Sandisk Corp (SNDK)
Strategy Cl A New (MSTR)
Moderna (MRNA)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
Nebius Group Shs Class A (NBIS)
Quantinuum Cl A Com

View all positions for Scientech Research

Top funds holding Acasti Pharma

HPM Partners
Eversept Partners
Bank of America Corporation
Vanguard Capital Management
Citadel Advisors
Maven Securities
Jane Street
Birchview Capital
Cantor Fitzgerald, L. P.
Two Sigma Investments
XTX Topco
Hrt Financial
Susquehanna International
BlackRock
Rangeley Capital

View all funds holding Acasti Pharma